Literature DB >> 18589784

[Observation of penetration, distribution and accumulation in human renal proximal tubular epithelial cells by aristololactam-I].

Pu Shang1, Xuan Wang, Xiao-Mei Li, Jia-Wei Tang, Shao-Qing Cai.   

Abstract

OBJECTIVE: To study whether aristololactam I (AL-I) can enter renal proximal tubular epithelial cells and the situation of intracellular distribution and accumulation.
METHOD: Cultured human renal proximal tubular epithelial cell line (HK-2) was used as the subject. Intracellular fluorescence from AL-I and its distribution are examined by fluorescence microscopy after a treatment with different concentration of AL-I, the intracellular accumulation of AL-I was also investigated by incubated cells in AL-I -free medium for 48 h after washing-out the media containing AL-I. RESULT: After treatment of AL-I (concentration from 5 microg x mL(-1) to 20 microg x mL(-1)), glaucous fluorescence could be observed inside renal proximal tubular epithelial cells at 0.5 h, and the fluorescence distributed only in cytoplasm while not be observed in nuclei. Moreover, the fluorescence of AL-I could be kept in cytoplasm for more than 48 h after washing out the media containing AL-I .
CONCLUSION: AL-I is able to enter renal proximal tubular epithelial cells in short time and accumulate in cytoplasm, but not enter nuclei. This property may contribute to the cytotoxic mechanism of renal injury induced by AL-I, which may partially explain the persistent renal toxicity of AAs and its metabolites in the development of aristolochic acid nephropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589784

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines.

Authors:  Suyan Liu; Zhong Xian; Yong Zhao; Lianmei Wang; Jingzhuo Tian; Chen Pan; Jiayin Han; Yushi Zhang; Chunying Li; Yan Yi; Chenyue Liu; Dunfang Wang; Jing Meng; Shasha Qin; Fang Wang; Aihua Liang
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.